Rare vardenafil-associated Stevens-Johnson syndrome: toxic epidermal necrolysis

BMJ Case Rep. 2022 Feb 28;15(2):e249013. doi: 10.1136/bcr-2022-249013.

Authors

Katerina Grafanaki¹, Spyridon Lygeros², Eleutheria Maria Vryzaki³, Sophia Georgiou³

Affiliations

¹ Department of Dermatology, Panepistemio Patron Tmema Iatrikes, Patras, Achaea, Greece grafanaki@med.upatras.gr.
² Ear, Nose, Throat Department, University General Hospital of Patras Greec, Patras, Greece.
³ Department of Dermatology, Panepistemio Patron Tmema Iatrikes, Patras, Achaea, Greece.

No abstract available

Keywords: ear, nose and throat; sexual health; skin; unwanted effects/adverse reactions; urinary and genital tract disorders.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents
Humans
Stevens-Johnson Syndrome* / etiology
Vardenafil Dihydrochloride / adverse effects

Substances

Anti-Bacterial Agents
Vardenafil Dihydrochloride